raav2-nd4
Gene therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Apr 1, 2011 (NCT01267422)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- NADH-ubiquinone oxidoreductase chain 4Supplementation
MT-ND4 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- raav2-nd4
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03428178 | N/A | Jan 8, 2018 | Huazhong University of Science and Technology |
| NCT03153293 | Phase 2/Phase 3 (Phase 3) | Sep 1, 2017 | Huazhong University of Science and Technology, Shiyan Taihe Hospital |
| NCT01267422 | N/A | Apr 1, 2011 | Huazhong University of Science and Technology |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Huazhong University of Science and Technology | Academic/Hospital | 3 | 3 | 2 | 2011 |
| Shiyan Taihe Hospital | Academic/Hospital | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1